Most lately, it's been recognized that conolidine and the above mentioned derivatives act about the atypical chemokine receptor 3 (ACKR3. Expressed in very similar spots as classical opioid receptors, it binds into a big range of endogenous opioids. Not like most opioid receptors, this receptor functions as being a scavenger and isn't going to acti